Expression and sequence analyses of p33ING1 gene in myeloid leukemia

American Journal of Hematology

Volumn 69, Issue 2, 2002, Pages 141-143

  Ito, K ^a   Kinjo, K ^a   Nakazato, T ^a   Ikeda, Y ^a   Kizaki, M ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Direct sequence; Myeloid leukemia; p33ING1; p53; RT PCR

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P33; PROTEIN P53; RNA; UNCLASSIFIED DRUG;

ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; MYELOID LEUKEMIA; POINT MUTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CELL CYCLE PROTEINS; COLONIC NEOPLASMS; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE EXPRESSION; GENES, TUMOR SUPPRESSOR; GROWTH INHIBITORS; HL-60 CELLS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MUTATION; NUCLEAR PROTEINS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0036154051     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10031     Document Type: Article

References (10)

1. ING1 promotes neoplastic transformation
2. ING1 cooperates with p53 in cell growth control
3. Cellular localization and chromosome mapping of a novel candidate tumor suppressor gene (ING1)
4. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: Identification of two distinct regions of preferential loss
5. ING1 mRNA in lymphoid malignancies
6. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)
7. Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features
8. ING1 and the relationship with p53 expression in human gastric cancer
9. ING1 candidate tumor suppressor
10. Molecular analysis of the candidate tumor suppressor gene ING1 in human head and neck tumors with 13q deletions